A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 426 participants.

Also called NCT02345044

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 426 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02345044
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02345044. Randomized; quadruple masking; primary purpose treatment. Start 2015-01 (registry gives no type); primary completion 2015-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects
Condition
Essential Hypertension
Intervention (Drug)
CS-3150
Intervention (Drug)
placebo
Intervention (Drug)
eplerenone
Lead sponsor
Daiichi Sankyo (class: industry)

Record details

Record id
cardio:ct-nct02345044
Content hash
3800825ef4063252d37a568e29b9d46624edeed1a2179c847dc4d9de6ade84c7